The North America Laser BPH Devices Market should witness market growth of 4.2% CAGR during the forecast period (2022-2028).
In most patients, the BPH worsens with age and can lead to serious damage and infection in the bladder. It can also cause blood in the urine and may also lead to kidney damage. Even though the causes of BPH are unclear, it is expected to occur mainly in older men. Where the hormone changes are thought to cause the disease, hormones from the testis may be the primary factor.
For instance, with aging in men, the amount of active testosterone in the blood decreases, whereas the estrogen levels remain the same. BPH may occur when the hormone changes trigger prostate cell growth. Another believed reason for the BPH cause includes the role of dihydrotestosterone (DHT). This male hormone assists in prostate development. Older men are supposed to have a higher level of DHT, with a lower level of testosterone.
Around one out of every four adults in Canada is obese. Between the years 1981 and 2007/09, the rate of obesity approximately doubled among both males and females in most age groups in age groups in the adult and youth categories. Factors influencing obesity include diet, physical activity, environmental factors, and socioeconomic status. The growing prevalence of obesity is expected to surge the cases of BPH as high obesity results in increased intra-abdominal pressure and other issues known to cause BPH. The instances of BPH are expected to increase, as also the utilization of laser BPH devices which will drive the market growth in the region.
The US market dominated the North America Laser BPH Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $169.2 Million by 2028. The Canada market is poised to grow at a CAGR of 6.2% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 5.9% during (2022-2028).
Based on End-user, the market is segmented into Hospitals, Clinics and Others. Based on Procedure, the market is segmented into Photoselective Vaporization of Prostate and Holium Laser Ablation. Based on Type, the market is segmented into Holmium Laser, Thulium Laser, Green Light Laser and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, OmniGuide, Inc., Richard Wolf GmbH, Coloplast Group, Agiliti, Inc., HealthTronics, Inc. (Altaris Capital Partners, LLC), Endo International PLC, Teleflex, Inc., Biolitec AG, and Metrum Cryoflex Sp. z o.o.
In most patients, the BPH worsens with age and can lead to serious damage and infection in the bladder. It can also cause blood in the urine and may also lead to kidney damage. Even though the causes of BPH are unclear, it is expected to occur mainly in older men. Where the hormone changes are thought to cause the disease, hormones from the testis may be the primary factor.
For instance, with aging in men, the amount of active testosterone in the blood decreases, whereas the estrogen levels remain the same. BPH may occur when the hormone changes trigger prostate cell growth. Another believed reason for the BPH cause includes the role of dihydrotestosterone (DHT). This male hormone assists in prostate development. Older men are supposed to have a higher level of DHT, with a lower level of testosterone.
Around one out of every four adults in Canada is obese. Between the years 1981 and 2007/09, the rate of obesity approximately doubled among both males and females in most age groups in age groups in the adult and youth categories. Factors influencing obesity include diet, physical activity, environmental factors, and socioeconomic status. The growing prevalence of obesity is expected to surge the cases of BPH as high obesity results in increased intra-abdominal pressure and other issues known to cause BPH. The instances of BPH are expected to increase, as also the utilization of laser BPH devices which will drive the market growth in the region.
The US market dominated the North America Laser BPH Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $169.2 Million by 2028. The Canada market is poised to grow at a CAGR of 6.2% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 5.9% during (2022-2028).
Based on End-user, the market is segmented into Hospitals, Clinics and Others. Based on Procedure, the market is segmented into Photoselective Vaporization of Prostate and Holium Laser Ablation. Based on Type, the market is segmented into Holmium Laser, Thulium Laser, Green Light Laser and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, OmniGuide, Inc., Richard Wolf GmbH, Coloplast Group, Agiliti, Inc., HealthTronics, Inc. (Altaris Capital Partners, LLC), Endo International PLC, Teleflex, Inc., Biolitec AG, and Metrum Cryoflex Sp. z o.o.
Scope of the Study
By End-user
- Hospitals
- Clinics
- Others
By Procedure
- Photoselective Vaporization of Prostate
- Holium Laser Ablation
By Type
- Holmium Laser
- Thulium Laser
- Green Light Laser
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- OmniGuide, Inc.
- Richard Wolf GmbH
- Coloplast Group
- Agiliti, Inc.
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
- Endo International PLC
- Teleflex, Inc.
- Biolitec AG
- Metrum Cryoflex Sp. z o.o.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Laser BPH Devices Market, by End User
1.4.2 North America Laser BPH Devices Market, by Procedure
1.4.3 North America Laser BPH Devices Market, by Type
1.4.4 North America Laser BPH Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Laser BPH Devices Market by End User
3.1 North America Hospitals Market by Country
3.2 North America Clinics Market by Country
3.3 North America Others Market by Country
Chapter 4. North America Laser BPH Devices Market by Procedure
4.1 North America Photoselective Vaporization of Prostate Market by Country
4.2 North America Holium Laser Ablation Market by Country
Chapter 5. North America Laser BPH Devices Market by Type
5.1 North America Holmium Laser Market by Country
5.2 North America Thulium Laser Market by Country
5.3 North America Green Light Laser Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Laser BPH Devices Market by Country
6.1 US Laser BPH Devices Market
6.1.1 US Laser BPH Devices Market by End User
6.1.2 US Laser BPH Devices Market by Procedure
6.1.3 US Laser BPH Devices Market by Type
6.2 Canada Laser BPH Devices Market
6.2.1 Canada Laser BPH Devices Market by End User
6.2.2 Canada Laser BPH Devices Market by Procedure
6.2.3 Canada Laser BPH Devices Market by Type
6.3 Mexico Laser BPH Devices Market
6.3.1 Mexico Laser BPH Devices Market by End User
6.3.2 Mexico Laser BPH Devices Market by Procedure
6.3.3 Mexico Laser BPH Devices Market by Type
6.4 Rest of North America Laser BPH Devices Market
6.4.1 Rest of North America Laser BPH Devices Market by End User
6.4.2 Rest of North America Laser BPH Devices Market by Procedure
6.4.3 Rest of North America Laser BPH Devices Market by Type
Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.2 Coloplast Group
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Endo International PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expense
7.4 Teleflex, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Geographical Expansions:
7.5 OmniGuide, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Trials and Approvals:
7.5.2.2 Acquisition and Mergers:
7.6 Biolitec AG
7.6.1 Company Overview
7.7 Metrum Cryoflex Sp. z o.o.
7.7.1 Company Overview
7.8 HealthTronics, Inc. (Altaris Capital Partners, LLC)
7.8.1 Company Overview
7.9 Agiliti, Inc.
7.9.1 Company Overview
7.10. Richard Wolf GmbH
7.10.1 Company Overview
Companies Mentioned
- Boston Scientific Corporation
- OmniGuide, Inc.
- Richard Wolf GmbH
- Coloplast Group
- Agiliti, Inc.
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
- Endo International PLC
- Teleflex, Inc.
- Biolitec AG
- Metrum Cryoflex Sp. z o.o.
Methodology
LOADING...
